WORKING DAYS
Mon-Sat: 10.00 to 7.00
Zexus Pharmaceuticals offers profitable Ophthalmic PCD Pharma Franchise opportunities with premium eye drops, strong support, and exclusive rights across India.
India’s eye care market is more than just busy—it’s growing at a speed that’s hard to ignore. We spend more hours staring at screens than ever, pollution irritates our eyes daily, and as more people live longer, age-related eye issues like cataracts and glaucoma are on the rise. This isn’t just a health trend; it’s a big, sustained demand wave for quality ophthalmic medicines. For pharma professionals, first-time investors, and even medical reps wanting to start on their own, finding a solid Ophthalmic PCD Pharma Franchise Company is a real opportunity in 2025. It feels personal, because clear vision is personal.
The business model makes sense. Pharma franchise partners get a ready-made portfolio, monopoly rights for a territory, and marketing support. This avoids the headaches of manufacturing and compliance from scratch. And in states like Karnataka, Gujarat, Punjab, Maharashtra, and Tamil Nadu, where private healthcare is strong, the PCD model in eye care is taking off. Doctors want consistent quality, pharmacies need reliable supply, and patients expect results. An Ophthalmic PCD Pharma Franchise Company that delivers on those basics can build a very stable, respectable business.
Here’s a practical list for 2025, blending specialist leaders with trusted large-pharma divisions. Always verify territory availability, credit norms, and dispatch SLAs in writing before signing anything.
👉 Website: https://zexuspharma.com
“At Zexus, we don’t just make eye care medicines, we feel proud to serve clarity of vision to people. For us, ophthalmology is not only about business but responsibility too.” That’s not just a tagline, it’s how we approach things day in, day out. We’re a specialist Ophthalmic PCD Pharma Franchise Company, and that focus makes a huge difference in quality and consistency.
Our ophthalmic range is wide: antibiotic eye drops (like Moxifloxacin and Gatifloxacin), lubricating drops for dry eyes (CMC 0.5% and 1%), anti-allergic solutions (Olopatadine), anti-inflammatory drops (Ketorolac), and even nutritional capsules with Lutein and Zeaxanthin for overall eye health. We cover both common and post-surgical needs, so our partners have a full basket for ophthalmologists.
We offer monopoly rights in many Indian states, which is critical for protecting a franchisee’s hard work. Plus, our marketing and promotional support—visual aids, samples, product literature—is designed to help real conversions in clinics, not just sit on a shelf. Our facilities are WHO-GMP and ISO certified, so partners can confidently stand behind the quality.
Eyeris Vision Care has built a reputation for high-quality, doctor-trusted ophthalmic formulations. Their portfolio covers a broad spectrum of eye conditions, and they are known for their ethical, partner-friendly approach. A solid choice for those who value consistency and specialist focus. Learn more about Eyeris Vision Care.
Spectra is known for innovative and affordable eye drops. They have a strong presence in tier-2 and tier-3 cities, making them a great partner for penetrating markets beyond the metros. Their model often appeals to new entrepreneurs. Explore Spectra Vision Care.
Vee Remedies has a diversified portfolio, and their ophthalmic division is gaining traction. They are seen as a reliable partner with a straightforward franchise model, making it easier for distributors to get started.
Micro Labs brings a research-driven approach to eye care. Their ophthalmic products are backed by solid clinical data, which helps in building credibility with specialist doctors. A good choice for partners targeting super-specialty clinics.
Swissvision focuses on premium, high-quality eye care solutions. They are a good fit for urban markets where patients and doctors have a preference for advanced, globally aligned formulations.
Talent Healthcare’s eye care division provides a balanced mix of products for common eye ailments. They are known for their supportive franchise policies and have been steadily growing their network.
Nemesis Pharma offers a practical range of ophthalmic products. Their focus on core, fast-moving formulations makes them a sensible partner for distributors who want to ensure quick stock rotation.
Jabs Biotech is another player with a dedicated ophthalmic line. They offer competitive pricing and franchise terms, making them an attractive option for budget-conscious entrepreneurs.
Cipla is a household name, and their eye care division, Cipla Vision Care, carries that weight of trust. Partnering with a brand like Cipla can make opening doors at clinics and pharmacies much easier, especially in competitive markets. Visit Cipla Vision Care.
The government’s new GST structure announced in 2025 has been a positive change for the ophthalmic sector. For anyone looking at an Ophthalmic PCD Pharma Franchise Company, this is good news for the bottom line.
Here’s the breakdown:
Most ophthalmic medicines (like antibiotic drops, anti-inflammatory solutions) now fall under the 12% GST slab, down from 18% earlier.
Essential ophthalmic products (like basic lubricating drops for dry eyes, certain anti-allergic drops) are in the 5% GST slab.
Cosmetic or advanced formulations (like premium preservative-free lubricants or cosmetic eye serums) might still be in the 18% GST slab.
What this means for franchise owners:
Better profit margins: The reduced GST directly adds to the distributor’s margin.
Easier Input Tax Credit (ITC): The process for claiming ITC has been simplified, which helps with cash flow.
Smoother filing: The new GST portal and updated procedures have reduced some of the compliance headaches.
💡 Example: If an eye drop was billed at ₹100, the old 18% GST made the final price ₹118. With the new 12% slab, it’s now ₹112. That ₹6 saving makes the product more affordable for patients and gives partners more room to compete on price.
When you’re looking for an Ophthalmic PCD Pharma Franchise Company, you need a partner, not just a supplier. That’s where Zexus stands out.
Monopoly-based franchise rights: We give our partners clear, exclusive territories. This protects your investment and ensures that your efforts in building relationships with doctors and pharmacies aren’t diluted.
Quality-driven ophthalmic manufacturing: Our WHO-GMP certified facilities mean every drop is made to the highest standards. In eye care, there’s no room for compromise.
Personal support in handling GST & compliance: We understand that rules change. “We always try to make things simple for our franchise partners, even in changing rules like GST.” We guide our partners through the compliance process to make sure they can focus on growing their business.
Starting is more straightforward than you might think.
Documents & licenses: You’ll need a Drug License (DL) and GST registration. A pharma license is also a common requirement. It’s best to get all your paperwork in order first.
Investment: The initial investment can range from ₹1 lakh to ₹5 lakhs, depending on the company, product range, and territory size. This covers your first stock, promotional materials, and some working capital.
Monopoly rights: Companies usually grant monopoly rights based on districts or specific regions. Always get this in writing. It should clearly state your area of operation.
Marketing & promotional support: A good Ophthalmic PCD Pharma Franchise Company provides visual aids, product literature, samples, and sometimes even a marketing strategy to help you get started.
The ophthalmic segment in India is not just growing; it’s booming. The need for quality eye care is undeniable, and the PCD franchise model offers a practical, profitable way to meet that need. For entrepreneurs and pharma professionals, this is a chance to build a business with purpose.
Among the many options, Zexus Pharmaceuticals stands at #1 as the preferred Ophthalmic PCD Pharma Franchise Company for many, because of a deep-rooted commitment to trust, personal care, and a strong, supportive network. Other great companies like Eyeris Vision Care, Swissvision Healthcare, and Cipla Vision Care are also shaping the industry with their quality offerings.
And with the new GST rules in 2025, franchise partners can now enjoy better profits and smoother operations. The timing couldn’t be better. If you’re looking to step into a business that offers both financial rewards and the satisfaction of helping people see a clearer world, the ophthalmic franchise space is waiting.


